Alaunos Therapeutics (TCRT) Total Debt (2016 - 2023)
Alaunos Therapeutics' (TCRT) quarterly Total Debt came in at $11.0 million in Q1 2023, down 54.81% YoY from $24.3 million in Q1 2022, and down 34.46% on a QoQ basis from $16.8 million in Q4 2022.
Alaunos Therapeutics (TCRT) Total Debt (2016 - 2023) Analysis & Trends
Alaunos Therapeutics (TCRT) has 4 years of Total Debt data on file, last reported at $11.0 million in Q1 2023.
- Quarterly Total Debt fell 54.81% year-over-year to $11.0 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $11.0 million (down 54.81% YoY) and the FY2022 annual result came in at $16.8 million, down 30.49% from the prior year.
- Total Debt slipped to $11.0 million in Q1 2023, from $16.8 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $24.5 million in Q2 2022 to a low of $11.0 million in Q1 2023.
- A 3-year average of $21.1 million and a median of $24.1 million in 2021 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2022 — Total Debt dropped 6.37% — and 2023, when it tumbled 54.81%.
- Tracing TCRT's Total Debt over 3 years: stood at $24.1 million in 2021, then slumped by 30.49% to $16.8 million in 2022, then plunged by 34.46% to $11.0 million in 2023.
- The last three Total Debt figures came in at $11.0 million (Q1 2023), $16.8 million (Q4 2022), and $22.7 million (Q3 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.34 Bn |
| 10 | Alaunos Therapeutics | 4.28 Mn | 4.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 10.99 Mn |
| Dec 31, 2022 | 16.77 Mn |
| Sep 30, 2022 | 22.67 Mn |
| Jun 30, 2022 | 24.52 Mn |
| Mar 31, 2022 | 24.32 Mn |
| Dec 31, 2021 | 24.12 Mn |
| Sep 30, 2021 | 24.21 Mn |
| Jun 30, 2016 | 119.05 Mn |